Comparison of Changes in the Lipid Profile of Postmenopausal Women With Early Stage Breast Cancer Treated With Exemestane or Letrozole-Reference-Cited by-同舟云学术

Comparison of Changes in the Lipid Profile of Postmenopausal Women With Early Stage Breast Cancer Treated With Exemestane or Letrozole

Published:2012-12 Issue:12 Volume:52 Page:1852-1860
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Bell Lauren Nicole,Nguyen Anne Thi Phuong,Li Lang,Desta Zeruesenay,Henry N. Lynn,Hayes Daniel F.,Wolff Antonio C.,Stearns Vered,Storniolo Anna Maria,Flockhart David A.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference31 articles.

1. In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients;Geisler;Clin Cancer Res,1998

2. Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, crossover study;Geisler;J Clin Oncol,2002

3. Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen;Dowsett;J Clin Oncol,2010

4. American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004;Winer;J Clin Oncol,2005

5. Aromatase inhibitors: mechanism of action and role in the treatment of breast cancer;Miller;Semin Oncol,2003

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of exemestane administration on the lipid profile in women: Meta-analysis of randomized controlled trials;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-04

2. Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2024-03-21

3. Lipid changes during endocrine therapy in early-stage breast cancer patients: A real-world study;Lipids in Health and Disease;2024-01-08

4. Dyslipidemia is associated with a poor prognosis of breast cancer in patients receiving neoadjuvant chemotherapy;BMC Cancer;2023-03-04

5. Lipid Changes During Endocrine Therapy in Breast Cancer Patients: The Results of a 5-Year Real-World Retrospective Analysis;Frontiers in Oncology;2022-01-17